News | February 28, 2022
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Fibromyalgia
Read More
Press Release | February 24, 2022
Pliant Therapeutics Announces Positive DSMB Safety Review and Commencement of Enrollment of Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis
Read More
Press Release | February 3, 2022
Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients
Read More
News | January 28, 2022
Cyrus Biotechnology CEO Lucas Nivon featured in Fierce Biotech Webinar
Read More
